Shire plc (NASDAQ:SHPG) is a constituent of the 350 company Biotechnology GICS industry group, which is part of the 782 company GICS Health Care sector. SHPG's market value is $44.8 billion which places it in the top 10% of its industry group. The current Portfolio Grader ranking for SHPG puts it 233 among the 350 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 538 among the 782 companies in the sector, and number 3,229 in the nearly 5,000 company Portfolio Grader universe. More
It’s Not Too Late to Profit on the Buffalo Wild Wings Stock Buyout
A private equity firm is considering a buyout of Buffalo Wild Wings, but a rival group is interested too. What does this mean for BWLD stock? More
Robust Quant Score Make Cellect Biotechnology (APOP) a Buy
Cellect Biotechnology Ltd (NULL:APOP) is ranked as a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing approach. The current Portfolio Grader recommendation on the shares has been in place for 4 months. More
Biogen (BIIB) a Hold on Uninspiring Sales Growth
Portfolio Grader currently ranks Biogen Inc (NASDAQ:BIIB) a Hold. With exclusive fundamental and quantitative metrics developed by Louis Navellier, this analytical tool assesses nearly 5,000 stocks weekly. BIIB has maintained this ranking for 3 months. More
Lowes (LOW) a Buy on Strong Quant Score
Currently, Lowes Companies (NYSE:LOW) has a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. LOW has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy. More
